Aquestive Therapeutics Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Financial Results and Issued FY24 Revenue Guidance Above Estimates.
Aquestive Therapeutics Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Financial Results and Issued FY24 Revenue Guidance Above Estimates.
Aquestive Therapeutics股價上漲，因該公司發佈了Q2業績，收入超過預期，併發布了FY24營業收入指引高於預期。
Aquestive Therapeutics Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Financial Results and Issued FY24 Revenue Guidance Above Estimates.
Aquestive Therapeutics公佈的第二季度財務業績好於預期，併發布了高於預期的24財年收入指引，股價走高。